<DOC>
	<DOCNO>NCT01268137</DOCNO>
	<brief_summary>This study aim assess efficacy safety DBS treatment patient suffer resistant major depression , mean random , control cross study .</brief_summary>
	<brief_title>DBS Treatment Resistant Major Depression</brief_title>
	<detailed_description>The first phase study consist implant electrode apply continuous stimulation patient stabilise clinically . This period anticipate 6 9 month . The next phase consist crossover study . Responders randomise either 2 group period 3 month : stimulation-on group stimulation-off group . Patients cross group 3 month . Fortnightly visit make entire study evaluate treatment efficacy patient tolerance</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>1 . Patients sex age 18 70 year . 2 . Patients diagnose MDD episode accord DSMIVTR criterion , resistant pharmacological treatment score 4 ThaseRush index , ECT contraindicate fail produce maintain response . 3 . Patients HRSD17 score 18 . 4 . Patients intellectual capacity facilitate adequate communication willing cooperate examination protocols study . 5 . Patients modify antidepressant treatment month prior study . 6 . Women childbearing age use medically approve contraceptive method . 7 . Patients grant informed consent writing . 1 . Female patient pregnant breastfeeding . 2 . Patients acute , serious unstable illness . 3 . Patients experience delirium hallucination , congruent otherwise mood . 4 . Patients history substance abuse ( tobacco caffeine ) . 5 . Patients concomitant psychiatric disorder ax I II DSM IVTR . h ) Patients general contraindication DBS ( pacemaker user , etc ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>MDD</keyword>
	<keyword>DBS</keyword>
</DOC>